Ampersand Capital Partners Acquires ProtaGene
Ampersand Capital Partners acquired ProtaGene for $40.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Ampersand Capital Partners
- Acquired Company
- ProtaGene
- Price
- $40.0M
- Acquisition Type
- Acquisition
- Announced
- July 1, 2021
Canonical: https://fsome.com/acquisitions/ampersand-capital-partners-acquires-protagene-8200737 · For the full deal terms, timeline, and press references, please enable JavaScript.